Arrowhead Pharmaceuticals logo
Arrowhead Pharmaceuticals ARWR
$ 19.23 -2.44%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Arrowhead Pharmaceuticals Long Term Debt 2011-2024 | ARWR

Annual Long Term Debt Arrowhead Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
105 M 78.8 M 23.3 M - - 2.1 M 2.33 M 2.53 M - - 50 K 839 K 607 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
105 M 50 K 23.9 M

Quarterly Long Term Debt Arrowhead Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
112 M 114 M 115 M 105 M 79.9 M 80.1 M 79.5 M 78.8 M - 22.7 M 22.5 M 23.3 M 22.9 M 23.3 M 19.7 M 20 M 20 M 20 M 14.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
115 M 14.4 M 54 M